Sofosbuvir
Back to searchMolecule Structure
Scientific Name
Sofosbuvir
Description of the Drug
Sofosbuvir is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08934
http://www.drugbank.ca/drugs/DB08934
Brand Name(s)
Psi-7977, gs-7977, Sovaldi
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Gilead Sciences Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus NS5B RNA-dependent RNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL5375 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2010114 | |
| PharmGKB | PA166122593 | |
| DrugBank | DB08934 | |
| PubChem: Thomson Pharma | 93367218 | |
| PubChem | 45375808 | |
| PDBe | WG6 | |
| BindingDB | 50239940 | |
| DrugCentral | 4811 | |
| Guide to Pharmacology | 7368 | |
| rxnorm | SOFOSBUVIR | SOVALDI |
| PubChem: Drugs of the Future | 136350055 | |
| ChEBI | 85083 | |
| ZINC | ZINC000100074252 |
